GI symptoms in systemic scleroderma unrelated to disease-specific medications

New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found no clear association between immunosuppressive or anti-fibrotic medications and...

Related Keywords

California ,United States ,Los Angeles ,Sarah Luebker ,University Of California ,Vanderbilt University Medical Center ,Collaborative National Quality ,American College Of Rheumatology ,American College ,Efficacy Registry ,Gastrointestinal Symptoms ,Systemic Scleroderma ,Gastrointestinal Tract ,Anti Fibrotic ,Scleroderma ,Diarrhea ,